pimagedine has been researched along with Amentia in 1 studies
pimagedine: diamine oxidase & nitric oxide synthase inhibitor; an advanced glycosylation end product inhibitor; used in the treatment of diabetic complications; structure
aminoguanidine : A one-carbon compound whose unique structure renders it capable of acting as a derivative of hydrazine, guanidine or formamide.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rodrigues, L | 1 |
| Biasibetti, R | 1 |
| Swarowsky, A | 1 |
| Leite, MC | 1 |
| Quincozes-Santos, A | 1 |
| Quilfeldt, JA | 1 |
| Achaval, M | 1 |
| Gonçalves, CA | 1 |
1 other study available for pimagedine and Amentia
| Article | Year |
|---|---|
Hippocampal alterations in rats submitted to streptozotocin-induced dementia model are prevented by aminoguanidine.
Topics: Analysis of Variance; Animals; Behavior, Animal; Dementia; Disease Models, Animal; Enzyme Inhibitors | 2009 |